Skip to Content

Notice

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Commission on Digestive Diseases.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Commission on Digestive Diseases.

Date: November 6, 2006.

Time: 9 a.m. to 5 p.m.

Agenda: Introductions; updates from Working Groups; Commission timeline and next steps; and general discussion. Pre-registration is required. Instructions will be available on the Commission's Web site at http://NCDD.niddk.nih.gov.

Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway (Rt. 1), Ballrooms E-F-G, Arlington, VA 22202.

Contact Person: Stephen P. James, MD, Director, Division of Digestive Diseases & Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, 6707 Democracy Blvd., Rm 677, Bethesda, MD 20892-5450, 301-594-7680, natlcommdd@mail.nih.gov.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Start Signature

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: September 29, 2006.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 06-8520 Filed 10-5-06; 8:45 am]

BILLING CODE 4140-01-M